Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Therapeutic Nanovaccine that Generates Anti‐Amyloid Antibodies and Amyloid‐specific Regulatory T Cells for Alzheimer's Disease
Mungyo Jung, Songmin Lee, Sohui Park, et al.
Advanced Materials (2022) Vol. 35, Iss. 3
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Pathological BBB Crossing Melanin-Like Nanoparticles as Metal-Ion Chelators and Neuroinflammation Regulators against Alzheimer’s Disease
Qianqian Huang, Chaoqing Jiang, Xue Xia, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 42
A Journey of Challenges and Victories: A Bibliometric Worldview of Nanomedicine since the 21st Century
Jingyu Wang, Wenling Zhao, Zhao Zhang, et al.
Advanced Materials (2024) Vol. 36, Iss. 15
Closed Access | Times Cited: 38
Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice
Pravin Yeapuri, Jatin Machhi, Yaman Lu, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 26
Looking Back, Moving Forward: Lipid Nanoparticles as a Promising Frontier in Gene Delivery
Daniela Pozzi, Giulio Caracciolo
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 11, pp. 1561-1573
Open Access | Times Cited: 25
Recent trends in treatment strategies for Alzheimer's disease and the challenges: A topical advancement
Ni Liu, Xiaohan Liang, Yu Chen, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102199-102199
Closed Access | Times Cited: 13
Engineering customized nanovaccines for enhanced cancer immunotherapy
JinYu Guo, Changhua Liu, Zhaoyang Qi, et al.
Bioactive Materials (2024) Vol. 36, pp. 330-357
Open Access | Times Cited: 12
Amyloid-β-targeting immunotherapies for Alzheimer's disease
Yi Jin, Qiaofei Du, Mingjie Song, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 346-365
Closed Access | Times Cited: 8
Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 1
Emerging nanotechnology for Alzheimer's disease: From detection to treatment
Nan Song, Si Sun, Ke Chen, et al.
Journal of Controlled Release (2023) Vol. 360, pp. 392-417
Closed Access | Times Cited: 20
A Personalized Cancer Nanovaccine that Enhances T‐Cell Responses and Efficacy Through Dual Interactions with Dendritic Cells and T Cells
Seokhyeong Go, Mungyo Jung, Suyoung Lee, et al.
Advanced Materials (2023) Vol. 35, Iss. 49
Closed Access | Times Cited: 19
Nanomedicines for Alzheimer's disease: Therapies based on pathological mechanisms
Guowang Cheng, Aihua Xie, Zhao Yan, et al.
Brain‐X (2023) Vol. 1, Iss. 3
Open Access | Times Cited: 17
Highly BBB-permeable nanomedicine reverses neuroapoptosis and neuroinflammation to treat Alzheimer's disease
Aihua Xie, Guowang Cheng, Jiaxin Wu, et al.
Biomaterials (2024) Vol. 312, pp. 122749-122749
Closed Access | Times Cited: 7
Alzheimer’s disease and immunotherapy
Wei Qin, Yana Pang, Shuya Nie, et al.
Current Medicine (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 6
Iron Oxide Nanoparticle-Incorporated Mesenchymal Stem Cells for Alzheimer’s Disease Treatment
Mungyo Jung, Hyeongseop Kim, Jung Won Hwang, et al.
Nano Letters (2023) Vol. 23, Iss. 2, pp. 476-490
Closed Access | Times Cited: 15
Multi-Enzyme Co-Expressed Ruthenium dioxide nanoparticles activate mitochondrial autophagy and regulate oxidative stress for Alzheimer's disease treatment
Yutong Chen, Ji‐an Wei, Liqiang Wang, et al.
Chemical Engineering Journal (2024) Vol. 492, pp. 151868-151868
Closed Access | Times Cited: 5
Nanoscale drug formulations for the treatment of Alzheimer's disease progression
Liu Liqin, Haini He, Bert N. La Du, et al.
RSC Advances (2025) Vol. 15, Iss. 6, pp. 4031-4078
Open Access
Peripheral and central neuroimmune mechanisms in Alzheimer’s disease pathogenesis
Shuo Zhang, Yue Gao, Yini Zhao, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access
Engineered nanoparticles for the treatment of Alzheimer’s disease
Jia Jia, Shuang Zhao, Jinghan Zhao, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Amyloid precursor protein and presenilin‐1 knock‐in immunodeficient mice exhibit intraneuronal Aβ pathology, microgliosis, and extensive neuronal loss
Pravin Yeapuri, Jatin Machhi, Emma G. Foster, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 4
Open Access
Differential roles of regulatory T cells in Alzheimer's disease
Abdollah Jafarzadeh, Abdolkarim Sheikhi, Zahra Jafarzadeh, et al.
Cellular Immunology (2023) Vol. 393-394, pp. 104778-104778
Closed Access | Times Cited: 10
The Major Hypotheses of Alzheimer’s Disease: Related Nanotechnology-Based Approaches for Its Diagnosis and Treatment
César Cáceres, Bernardita Heusser, Alexandra L. Garnham, et al.
Cells (2023) Vol. 12, Iss. 23, pp. 2669-2669
Open Access | Times Cited: 10
The Role of T-lymphocytes in Central Nervous System Diseases
Jianing Shen, Ning Bian, Lu Zhao, et al.
Brain Research Bulletin (2024) Vol. 209, pp. 110904-110904
Open Access | Times Cited: 3
Immune-Modulating Lipid Nanomaterials for the Delivery of Biopharmaceuticals
Song‐Hee Kim, Boseung Choi, Yoojin Kim, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1760-1760
Open Access | Times Cited: 7
Treatment with glatiramer acetate in APPswe/PS1dE9 mice at an early stage of Alzheimer’s disease prior to amyloid-beta deposition delays the disease’s pathological development and ameliorates cognitive decline
Zengyong Huang, Zhuo Gong, Yongtai Lin, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 2
Emerging Trends on Nanovaccine Administration and Functionalization Strategies for Immunization
Hitesh Kumar Dewangan, Kamal Shah, Rajiv Sharma, et al.
Journal of Computational Biophysics and Chemistry (2024) Vol. 23, Iss. 05, pp. 575-604
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top